Coca-Cola and PepsiCo: No plans to enter cannabis space at the moment

By Rachel Arthur

- Last updated on GMT

Both Coca-Cola and PepsiCo are cautious about the cannabis category. Pic:getty/nastastic
Both Coca-Cola and PepsiCo are cautious about the cannabis category. Pic:getty/nastastic
Coca-Cola and PepsiCo both say they have no current plans to enter the cannabis space, contrary to recent rumours.

With recreational cannabis becoming legal in Canada this month, and a number of US states appearing to move in a similar direction, the market for cannabis infused beverages and other edibles has been opening up.

Innovation and cannabis launches have primarily been coming from smaller companies;with a key question being how the big multinationals will act as the category emerges.

While Constellation Brands, Molson Coors and Heineken have started exploring the category, both Coca-Cola and PepsiCo have this month stated they have no plans to enter the sector at this stage. 

US market: 'Federally, these things are still not legal'

Wine and spirits giant Constellation Brands has invested $4bn in Canadian cannabis company Canopy Growth​ to develop cannabis infused beverages; as well as investigate the wider cannabis space. Heineken’s Lagunitas, meanwhile, has already launched a cannabis infused sparkling water.​ ​And Molson Coors Canada has created a joint venture called Truss​ with Canadian cannabis producer The Hydropothecary Corporation (HEXO), to develop non-alcoholic, cannabis infused beverages in Canada. 

Last month it was suggested that Coca-Cola was in talks with Aurora Cannabis, a Canadian marijuana producer, with the drinks giant reported to be ‘closely watching’ the growth of non-pyschoactive CBD in beverages.

But asked about the company’s plans in the cannabis category during this week’s earnings call with analysts, CEO James Quincey stated: “We don't have any plans at this stage to get into this space.”

His comments follow on from a statement made by Coca-Cola last month in response to speculation over its interest in the segment: “We have no interest in marijuana or cannabis. Along with many others in the beverage industry, we are closely watching the growth of non-psychoactive CBD as an ingredient in functional wellness beverages around the world.  The space is evolving quickly. No decisions have been made at this time.”

PepsiCo, too, appears to have a similar stance on cannabis. Speaking in its Q3 earnings call earlier this month, Hugh F. Johnston, vice chairman, executive VP and CFO, said the company was watching the space carefully but had no current plans to enter it.

“I think it's fair to say we look at everything,” ​he told analysts. “But I think the difficulties in investing in that category, particularly in the US where federally these things are still not legal, are quite a considerable challenge.

“So we look at everything: but certainly no plans at this point to do anything.”

Related topics Brands & manufacturers Botanicals

Related news

Related products

show more

Fueling Athletes with Nature for Peak Performance

Fueling Athletes with Nature for Peak Performance

Content provided by SEPPIC INC | 07-Oct-2024 | White Paper

For many years, pine bark extracts have been harnessed for their potent anti-oxidant and anti-inflammatory properties, delivering a wide array of health...

ACTRISAVE™ NATURAL SUPPORT FOR SKIN AND MALE HAIR

ACTRISAVE™ NATURAL SUPPORT FOR SKIN AND MALE HAIR

Content provided by BIONAP BIOACTIVE NATURAL PRODUCTS | 30-Sep-2024 | Product Brochure

ACTRISAVE™ is a powdered extract obtained from the patented association between black rice (Oryza sativa L.) and the flowers of prickly pear (Opuntia ficus-indica...

Tackling Metabolic Health with HIMABERB® Berberine

Tackling Metabolic Health with HIMABERB® Berberine

Content provided by Pharma Base S.A. | 18-Sep-2024 | White Paper

Metabolic health is a prevalent and rapidly growing global challenge. In recent years, there has been mounting clinical evidence to support the use of...

Fast acting Specialty Lutein Esters

Fast acting Specialty Lutein Esters

Content provided by Ennature Biopharma, a Division of India Glycols Limited | 16-Sep-2024 | Case Study

Xanthogreen® is a clinically validated, clean label ingredient from marigold flowers that helps boost your eye health with visible effects in as little...

Related suppliers

Follow us

Products

View more

Webinars